{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "36921274",
  "DateCompleted": {
    "Year": "2023",
    "Month": "03",
    "Day": "20"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "02"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "03",
        "Day": "17"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.15585/mmwr.mm7153a1"
    ],
    "Journal": {
      "ISSN": "1545-861X",
      "JournalIssue": {
        "Volume": "71",
        "Issue": "53",
        "PubDate": {
          "Year": "2023",
          "Month": "Mar",
          "Day": "17"
        }
      },
      "Title": "MMWR. Morbidity and mortality weekly report",
      "ISOAbbreviation": "MMWR Morb Mortal Wkly Rep"
    },
    "ArticleTitle": "Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.",
    "Pagination": {
      "StartPage": "1637",
      "EndPage": "1646",
      "MedlinePgn": "1637-1646"
    },
    "Abstract": {
      "AbstractText": [
        "During June-October 2022, the SARS-CoV-2 Omicron BA.5 sublineage accounted for most of the sequenced viral genomes in the United States, with further Omicron sublineage diversification through November 2022.* Bivalent mRNA vaccines contain an ancestral SARS-CoV-2 strain component plus an updated component of the Omicron BA.4/BA.5 sublineages. On September 1, 2022, a single bivalent booster dose was recommended for adults who had completed a primary vaccination series (with or without subsequent booster doses), with the last dose administered \u22652 months earlier (1). During September 13-November 18, the VISION Network evaluated vaccine effectiveness (VE) of a bivalent mRNA booster dose (after 2, 3, or 4 monovalent doses) compared with 1) no previous vaccination and 2) previous receipt of 2, 3, or 4 monovalent-only mRNA vaccine doses, among immunocompetent adults aged \u226518 years with an emergency department/urgent care (ED/UC) encounter or hospitalization for a COVID-19-like illness.<sup>\u2020</sup> VE of a bivalent booster dose (after 2, 3, or 4 monovalent doses) against COVID-19-associated ED/UC encounters was 56% compared with no vaccination, 32% compared with monovalent vaccination only with last dose 2-4 months earlier, and 50% compared with monovalent vaccination only with last dose \u226511 months earlier. VE of a bivalent booster dose (after 2, 3, or 4 monovalent doses) against COVID-19-associated hospitalizations was 59% compared with no vaccination, 42% compared with monovalent vaccination only with last dose 5-7 months earlier, and 48% compared with monovalent vaccination only with last dose \u226511 months earlier. Bivalent vaccines administered after 2, 3, or 4 monovalent doses were effective in preventing medically attended COVID-19 compared with no vaccination and provided additional protection compared with past monovalent vaccination only, with relative protection increasing with time since receipt of the last monovalent dose. All eligible persons should stay up to date with recommended COVID-19 vaccinations, including receiving a bivalent booster dose. Persons should also consider taking additional precautions to avoid respiratory illness this winter season, such as masking in public indoor spaces, especially in areas where COVID-19 community levels are high."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Tenforde",
        "ForeName": "Mark W",
        "Initials": "MW"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Weber",
        "ForeName": "Zachary A",
        "Initials": "ZA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Natarajan",
        "ForeName": "Karthik",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Klein",
        "ForeName": "Nicola P",
        "Initials": "NP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kharbanda",
        "ForeName": "Anupam B",
        "Initials": "AB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Stenehjem",
        "ForeName": "Edward",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Embi",
        "ForeName": "Peter J",
        "Initials": "PJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Reese",
        "ForeName": "Sarah E",
        "Initials": "SE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Naleway",
        "ForeName": "Allison L",
        "Initials": "AL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Grannis",
        "ForeName": "Shaun J",
        "Initials": "SJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "DeSilva",
        "ForeName": "Malini B",
        "Initials": "MB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ong",
        "ForeName": "Toan C",
        "Initials": "TC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gaglani",
        "ForeName": "Manjusha",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Han",
        "ForeName": "Jungmi",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Dickerson",
        "ForeName": "Monica",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Fireman",
        "ForeName": "Bruce",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Dascomb",
        "ForeName": "Kristin",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Irving",
        "ForeName": "Stephanie A",
        "Initials": "SA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Vazquez-Benitez",
        "ForeName": "Gabriela",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Rao",
        "ForeName": "Suchitra",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Konatham",
        "ForeName": "Deepika",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Patel",
        "ForeName": "Palak",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Schrader",
        "ForeName": "Kristin E",
        "Initials": "KE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lewis",
        "ForeName": "Ned",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Grisel",
        "ForeName": "Nancy",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "McEvoy",
        "ForeName": "Charlene",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Murthy",
        "ForeName": "Kempapura",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Griggs",
        "ForeName": "Eric P",
        "Initials": "EP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Rowley",
        "ForeName": "Elizabeth A K",
        "Initials": "EAK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Zerbo",
        "ForeName": "Ousseny",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Arndorfer",
        "ForeName": "Julie",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Dunne",
        "ForeName": "Margaret M",
        "Initials": "MM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Goddard",
        "ForeName": "Kristin",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ray",
        "ForeName": "Caitlin",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Zhuang",
        "ForeName": "Yan",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Timbol",
        "ForeName": "Julius",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Najdowski",
        "ForeName": "Morgan",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Yang",
        "ForeName": "Duck-Hye",
        "Initials": "DH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hansen",
        "ForeName": "John",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ball",
        "ForeName": "Sarah W",
        "Initials": "SW"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Link-Gelles",
        "ForeName": "Ruth",
        "Initials": "R"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Corrected and Republished Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "MMWR Morb Mortal Wkly Rep",
    "NlmUniqueID": "7802429",
    "ISSNLinking": "0149-2195"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Messenger"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Vaccines, Combined"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "MMWR Morb Mortal Wkly Rep. 2023 Mar 17;72(11):292",
      "PMID": "36927730"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Vaccine Efficacy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Emergency Service, Hospital"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hospitalization"
    },
    {
      "QualifierName": [],
      "DescriptorName": "RNA, Messenger"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Vaccines, Combined"
    }
  ],
  "CoiStatement": "All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Nicola P. Klein received grants from Pfizer, Merck, GlaxoSmithKline, and Sanofi Pasteur. Allison L. Naleway received grants from Pfizer and Vir Biotechnology. Suchitra Rao received grants from GlaxoSmithKline. Charlene McEvoy received grants from AztraZeneca. No other potential conflicts of interest were disclosed."
}